Kazuhiro Ogi

5PUBLICATIONS
13CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 27, 2026
Primary Small Cell Neuroendocrine Carcinoma of the Sublingual Gland Treated With Definitive Chemoradiotherapy: A Case Report.

|Sep 30, 2025
Notch1 Mutation Represents a Potential Therapeutic Target to Enhance Immune Recognition in Oral Squamous Cell Carcinoma.

Takahiro Iwamoto, Kazuhiro Ogi, Takafumi Nakagaki

|May 21, 2025
Effect of human survivin-2B-specific cytotoxic CD8+ T lymphocytes on CD44+/- HSC-2 and HSC-3 oral cancer cells.

Sho Miyamoto, Azuna Osaki, Aiko Murai

|Mar 16, 2024
Notch signaling genes and CD8<sup>+</sup> T-cell dynamics: Their contribution to immune-checkpoint inhibitor therapy in oral squamous cell carcinoma: A retrospective study.

Kazuhiro Ogi, Takahiro Iwamoto, Takashi Sasaya

|Jun 23, 2017
Additive effect of radiosensitization by 2-deoxy-D-glucose delays DNA repair kinetics and suppresses cell proliferation in oral squamous cell carcinoma.

Mayumi Kawata, Kazuhiro Ogi, Koyo Nishiyama

Pageof 1

Frequent Collaborators

3 joint publications

Sho Miyamoto

3 joint publications

Akihiro Miyazaki

1 joint publications

Yoshihiko Hirohashi

1 joint publications

Takayuki Kanaseki